martes, 7 de julio de 2009
Marketing Mix of Leading Pharma Advertisers 2008/2009 (I)
Los cambios más significativos en cuanto a "caidas" serian Wyeth (baja 4 puestos) y Schering-Plough y Bristol-Myers Squib Co (bajan 3).
Por el contrario escala posición Eli Lilly (sube 3)
Basados en los gastos de los años anteriores (2008/2007)
The list is based on "measured media" spending across 19 media and includes estimates of "unmeasured media," which includes direct marketing, product placement, and most notably, paid Internet search, which some analysts estimate is about 40% of the total Internet ad spend of companies in general.
Datos que tomé "prestados" de John Mack
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario